IL-10, which is increased in the serum of patients with B-cell NHL, including DLBCL, and is produced by lymphoma cells, was shown to decrease HLA-DR expression on monocytes, and IL-10-induced CD14+HLA-DRlow cells inhibited the activation and proliferation of T cells [105]. Here, IL10 is linked to B-cell non-Hodgkin lymphoma.